Hepatitis C: the path towards effective universal therapy

Slides:



Advertisements
Similar presentations
The Circadian Timekeeping System of Drosophila Paul E. Hardin Current Biology Volume 15, Issue 17, Pages R714-R722 (September 2005) DOI: /j.cub
Advertisements

Two views of brain function Marcus E. Raichle Trends in Cognitive Sciences Volume 14, Issue 4, Pages (April 2010) DOI: /j.tics
Toward a Structure Determination Method for Biomineral-Associated Protein Using Combined Solid- State NMR and Computational Structure Prediction David.
The Microbiome and Cancer: Is the ‘Oncobiome’ Mirage Real? Ryan M. Thomas, Christian Jobin Trends in Cancer Volume 1, Issue 1, Pages (September 2015)
The Origins and Evolution of Vertebrate Metamorphosis Vincent Laudet Current Biology Volume 21, Issue 18, Pages R726-R737 (September 2011) DOI: /j.cub
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Volume 80, Issue 3, Pages (March 2009)
Cautious optimism on public health in post-earthquake Haiti
Pharmacogenetics and future drug development and delivery
Volume 349, Issue 9057, Pages (April 1997)
Thank God for Richard Dawkins?
Long-term effects of hormone replacement therapy
Volume 391, Issue 10123, Pages (March 2018)
The commercial determinants of health
Optimum timing of treatment for hepatitis C infection relative to liver transplantation  Dr Audrey Coilly, MD, Bruno Roche, MD, Prof Jean-Charles Duclos-Vallée,
At high risk: becoming a mother in the Peruvian Andes
Controlling Ebola: key role of Ebola treatment centres
John N Nkengasong, Philip Onyebujoh  The Lancet 
Long-term effects of hormone replacement therapy
Political factors behind US global AIDS programmes slow-down
Klebsiella pneumoniae liver abscesses
One more reason to fund the Global Fund
Hormones and bones The Lancet Volume 349, Pages S20-S23 (March 1997)
Aspirin in the prevention of cancer – Author's reply
Network for strong, national, public health institutes in west Africa
Gene therapy—where are we?
Treatment of Helicobacter pylori in Latin America
Effective cross-sector collaborations create sustainability
Volume 382, Issue 9906, Pages (November 2013)
A next-generation Alzheimer's centre for Madrid
Organisation of the care of patients with heart failure
Incident diabetes in clinical trials of antihypertensive drugs
HIV myths should not be resuscitated
Challenges to eliminate rabies virus infection in China by 2020
Pharmacogenetic testing in the UK clinical setting
Pesticide self-poisoning: thinking outside the box
James E Scriven, David G Lalloo, Graeme Meintjes 
Effect of development assistance on domestic health expenditures
Volume 12, Issue 9, Pages (September 2013)
Volume 362, Pages s6-s7 (December 2003)
Confessions of a journal junkie
Sven Pischke, Patrick Behrendt, Michael P Manns, Heiner Wedemeyer 
Telling it like it isn't: truth and lies in a post-9/11 world
Hidden from history? A brief modern history of the psychiatric “treatment” of lesbian and bisexual women in England  Sarah Carr, Helen Spandler  The Lancet.
Thank God for Richard Dawkins?
Low-technology approaches
Diagnosis of tuberculous meningitis with invasive pulmonary sampling
Prof GJB van Ommen, PhD, E Bakker, PhD, JT den Dunnen, PhD  The Lancet 
Volume 375, Issue 9714, Pages (February 2010)
Thank you to our diverse (but not diverse enough) reviewers
ACST: which subgroups will benefit most from carotid endarterectomy?
Volume 373, Issue 9672, Pages (April 2009)
Arlene Chan, Marc Buyse, Bin Yao  The Lancet Oncology 
Costs of eliminating HIV in South Africa have been underestimated
Nivolumab plus interferon-γ in the treatment of intractable mucormycosis  David Grimaldi, Olivier Pradier, Richard S Hotchkiss, Jean-Louis Vincent  The.
GBD 2016 estimates problematic for South Africa
Liver failure after long-term nucleoside antiretroviral therapy
A remarkable report card on progress in COPD
Difficulties of surgery in the developing world: a personal view
Political factors behind US global AIDS programmes slow-down
Volume 21, Issue 9, Pages (September 2014)
Volume 366, Issue 9491, Pages (September 2005)
Volume 1, Issue 2, Pages (July 2014)
Refining treatment choices for ADHD
Effect of consent rituals on mortality in emergency care research
The dilemma of vaginal breech delivery worldwide
Hepatitis C: the path towards effective universal therapy
Volume 21, Issue 9, Pages (September 2014)
Correction to Lancet Gastroenterol Hepatol 2018; 4: 435–44
Autism, maths, and sex: the special triangle
Presentation transcript:

Hepatitis C: the path towards effective universal therapy Lionel Piroth, Christian Rabaud, David Rey, Jean-Luc Schmit, Catherine Chirouze, Geneviève Beck-Wirth, Olivier Robineau, Firouze Bani-Sadr  The Lancet  Volume 388, Issue 10049, Pages 1051-1052 (September 2016) DOI: 10.1016/S0140-6736(16)31540-9 Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure Main reasons for patients not having treatment in the InterCorevih Nord-Est (ICONE) Several reasons are possible for each patient. HCV=hepatitis C virus The Lancet 2016 388, 1051-1052DOI: (10.1016/S0140-6736(16)31540-9) Copyright © 2016 Elsevier Ltd Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.